These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exploring the Effect of Halogenation in a Series of Potent and Selective A Prieto-Díaz R; González-Gómez M; Fojo-Carballo H; Azuaje J; El Maatougui A; Majellaro M; Loza MI; Brea J; Fernández-Dueñas V; Paleo MR; Díaz-Holguín A; Garcia-Pinel B; Mallo-Abreu A; Estévez JC; Andújar-Arias A; García-Mera X; Gomez-Tourino I; Ciruela F; Salas CO; Gutiérrez-de-Terán H; Sotelo E J Med Chem; 2023 Jan; 66(1):890-912. PubMed ID: 36517209 [TBL] [Abstract][Full Text] [Related]
5. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes. El Maatougui A; Azuaje J; González-Gómez M; Miguez G; Crespo A; Carbajales C; Escalante L; García-Mera X; Gutiérrez-de-Terán H; Sotelo E J Med Chem; 2016 Mar; 59(5):1967-83. PubMed ID: 26824742 [TBL] [Abstract][Full Text] [Related]
6. Trifluorinated Pyrimidine-Based A Mallo-Abreu A; Majellaro M; Jespers W; Azuaje J; Caamaño O; García-Mera X; Brea JM; Loza MI; Gutiérrez-de-Terán H; Sotelo E J Med Chem; 2019 Oct; 62(20):9315-9330. PubMed ID: 31557025 [TBL] [Abstract][Full Text] [Related]
7. Enantiospecific Recognition at the A Carbajales C; Azuaje J; Oliveira A; Loza MI; Brea J; Cadavid MI; Masaguer CF; García-Mera X; Gutiérrez-de-Terán H; Sotelo E J Med Chem; 2017 Apr; 60(8):3372-3382. PubMed ID: 28368607 [TBL] [Abstract][Full Text] [Related]
8. Fluorescent-Labeled Selective Adenosine A Köse M; Gollos S; Karcz T; Fiene A; Heisig F; Behrenswerth A; Kieć-Kononowicz K; Namasivayam V; Müller CE J Med Chem; 2018 May; 61(10):4301-4316. PubMed ID: 29681156 [TBL] [Abstract][Full Text] [Related]
9. Exploring Biginelli-based scaffolds as A Prieto-Díaz R; Fojo-Carballo H; Majellaro M; Tandarić T; Azuaje J; Brea J; Loza MI; Barbazán J; Salort G; Chotalia M; Rodríguez-Pampín I; Mallo-Abreu A; Rita Paleo M; García-Mera X; Ciruela F; Gutiérrez-de-Terán H; Sotelo E Biomed Pharmacother; 2024 Apr; 173():116345. PubMed ID: 38442670 [TBL] [Abstract][Full Text] [Related]
10. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation. Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603 [TBL] [Abstract][Full Text] [Related]
11. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists. Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859 [TBL] [Abstract][Full Text] [Related]
12. 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists. Taliani S; Pugliesi I; Barresi E; Simorini F; Salerno S; La Motta C; Marini AM; Cosimelli B; Cosconati S; Di Maro S; Marinelli L; Daniele S; Trincavelli ML; Greco G; Novellino E; Martini C; Da Settimo F J Med Chem; 2012 Feb; 55(4):1490-9. PubMed ID: 22257095 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of endogenous A Goulding J; May LT; Hill SJ Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel xanthine derivatives as potent and selective A Basu S; Barawkar DA; Ramdas V; Patel M; Waman Y; Panmand A; Kumar S; Thorat S; Naykodi M; Goswami A; Reddy BS; Prasad V; Chaturvedi S; Quraishi A; Menon S; Paliwal S; Kulkarni A; Karande V; Ghosh I; Mustafa S; De S; Jain V; Banerjee ER; Rouduri SR; Palle VP; Chugh A; Mookhtiar KA Eur J Med Chem; 2017 Jul; 134():218-229. PubMed ID: 28415011 [TBL] [Abstract][Full Text] [Related]
15. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists. Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777 [TBL] [Abstract][Full Text] [Related]
16. New 8-substituted xanthiene derivatives as potent bronchodilators. Berk B; Akgün H; Erol K; Sirmagül B; Gao ZG; Jacobson KA Farmaco; 2005; 60(11-12):974-80. PubMed ID: 16243321 [TBL] [Abstract][Full Text] [Related]
17. Irreversible Antagonists for the Adenosine A Temirak A; Schlegel JG; Voss JH; Vaaßen VJ; Vielmuth C; Claff T; Müller CE Molecules; 2022 Jun; 27(12):. PubMed ID: 35744918 [TBL] [Abstract][Full Text] [Related]
18. Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A Vlachodimou A; de Vries H; Pasoli M; Goudswaard M; Kim SA; Kim YC; Scortichini M; Marshall M; Linden J; Heitman LH; Jacobson KA; IJzerman AP Biochem Pharmacol; 2022 Jun; 200():115027. PubMed ID: 35395239 [TBL] [Abstract][Full Text] [Related]
19. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A Falsini M; Squarcialupi L; Catarzi D; Varano F; Betti M; Dal Ben D; Marucci G; Buccioni M; Volpini R; De Vita T; Cavalli A; Colotta V J Med Chem; 2017 Jul; 60(13):5772-5790. PubMed ID: 28590753 [TBL] [Abstract][Full Text] [Related]
20. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation. Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]